The SIILTIBCY test is now available worldwide through the STOP TB GDF for $1.50 per dose. This novel testing option provides an alternative to PPD testing and is the first MTB antigen based skin test to be approved and recommended by the Global Fund’s Expert Review Panel. This new test has been shown to provide greater specificity in detecting TB in patients who received the BCG vaccine. Read more here.
top of page
Recent Posts
See AllJohn Green’s new book Everything is Tuberculosis is scheduled to be published in Spring 2025. The novel laces the experiences of Henry, a...
70
The WHO has released the 2024 Global Tuberculosis Report and it places TB as the leading infectious disease killer, surpassing COVID-19....
120
Phumeza Tisile was treated for MDR-TB in 2010 and suffered severe side effects from the drug, kanamycin. Her experiences drove her to...
220
bottom of page
コメント